T1	CHEM 1 13	Dexametasona
#1	AnnotatorNotes T1	C0011777; dexamethasone; Organic Chemical · Pharmacologic Substance
T2	CHEM 29 39	Rimexolona
#2	AnnotatorNotes T2	C0140594; rimexolone; Organic Chemical · Pharmacologic Substance
T3	PROC 47 66	Estudio comparativo
#3	AnnotatorNotes T3	C1579762; comparative study research; Research Activity
T4	PROC 94 114	cirugía de cataratas
#4	AnnotatorNotes T4	C2939459; Cataract surgery; Therapeutic or Preventive Procedure
T5	DISO 153 172	efectos secundarios
#5	AnnotatorNotes T5	C0041755; Adverse reaction to drug; Pathologic Function | C0559546; Adverse reactions; Pathologic Function | C0879626; Adverse effects; Pathologic Function
T6	CHEM 179 189	rimexolona
#6	AnnotatorNotes T6	C0140594; rimexolone; Organic Chemical · Pharmacologic Substance
T7	CHEM 201 213	dexametasona
#7	AnnotatorNotes T7	C0011777; dexamethasone; Organic Chemical · Pharmacologic Substance
T8	PROC 225 251	tratamiento postoperatorio
T9	PROC 258 277	cirugía de catarata
#8	AnnotatorNotes T9	C2939459; Cataract surgery; Therapeutic or Preventive Procedure
T10	PROC 389 401	intervenidos
#9	AnnotatorNotes T10	C0543467; Operative Surgical Procedures; Therapeutic or Preventive Procedure
T11	DISO 405 414	cataratas
#10	AnnotatorNotes T11	C0086543; Cataract; Anatomical Abnormality
T12	PROC 424 442	facoemulsificación
#11	AnnotatorNotes T12	C0282545; Phacoemulsification; Therapeutic or Preventive Procedure | C2193446; Aspiration of cataract by phacoemulsification; Therapeutic or Preventive Procedure
T13	DISO 448 479	complicaciones intraoperatorias
#12	AnnotatorNotes T13	C0021890; Intraoperative Complications; Pathologic Function
T14	CHEM 592 604	dexametasona
#13	AnnotatorNotes T14	C0011777; dexamethasone; Organic Chemical · Pharmacologic Substance
T15	PROC 625 653	tratamiento antiinflamatorio
T16	CHEM 701 711	rimexolona
#14	AnnotatorNotes T16	C0140594; rimexolone; Organic Chemical · Pharmacologic Substance
T17	PROC 741 746	pauta
#15	AnnotatorNotes T17	C0935576; treatment guideline; Therapeutic or Preventive Procedure
T18	DISO 825 846	hiperemia conjuntival
#16	AnnotatorNotes T18	C1761613; Conjunctival hyperemia; Finding
T19	ANAT 852 878	células en cámara anterior
#17	AnnotatorNotes T19	C0423282; Anterior chamber cells; Finding
T20	ANAT 924 931	corneal
#18	AnnotatorNotes T20	C0010031; Cornea; Body Part, Organ, or Organ Component | C1278889; Entire cornea; Body Part, Organ, or Organ Component
T21	DISO 950 963	edema macular
#19	AnnotatorNotes T21	C0271051; Macular retinal edema; Disease or Syndrome
T22	PROC 994 1001	cirugía
#20	AnnotatorNotes T22	C0543467; Operative Surgical Procedures; Therapeutic or Preventive Procedure
T23	CHEM 1034 1042	fármacos
#21	AnnotatorNotes T23	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T24	PROC 1111 1118	cirugía
#22	AnnotatorNotes T24	C0543467; Operative Surgical Procedures; Therapeutic or Preventive Procedure
T25	CHEM 1287 1299	dexametasona
#23	AnnotatorNotes T25	C0011777; dexamethasone; Organic Chemical · Pharmacologic Substance
T26	CHEM 1413 1423	Rimexolona
#24	AnnotatorNotes T26	C0140594; rimexolone; Organic Chemical · Pharmacologic Substance
T27	CHEM 1444 1451	fármaco
#25	AnnotatorNotes T27	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T28	CHEM 1483 1495	dexametasona
#26	AnnotatorNotes T28	C0011777; dexamethasone; Organic Chemical · Pharmacologic Substance
T29	PROC 1502 1528	tratamiento postoperatorio
T30	PROC 1535 1554	cirugía de catarata
#27	AnnotatorNotes T30	C2939459; Cataract surgery; Therapeutic or Preventive Procedure
T31	DISO 105 114	cataratas
#28	AnnotatorNotes T31	C0086543; Cataract; Anatomical Abnormality
T32	DISO 269 277	catarata
#29	AnnotatorNotes T32	C0086543; Cataract; Anatomical Abnormality
T33	PROC 300 331	Estudio de cohortes prospectivo
#30	AnnotatorNotes T33	C1709709; Prospective Cohort Study; Research Activity
T34	CHEM 558 561	DEX
#31	AnnotatorNotes T34	C0011777; dexamethasone; Organic Chemical · Pharmacologic Substance
T35	CHEM 637 653	antiinflamatorio
#32	AnnotatorNotes T35	C0003209; Anti-Inflammatory Agents; Pharmacologic Substance
T36	PROC 793 820	estudiado la agudeza visual
#33	AnnotatorNotes T36	C0200150; Visual acuity testing; Diagnostic Procedure
T37	ANAT 835 846	conjuntival
#34	AnnotatorNotes T37	C0009758; conjunctiva; Body Part, Organ, or Organ Component | C1278888; Entire conjunctiva; Body Part, Organ, or Organ Component
T38	PROC 893 912	presión intraocular
#35	AnnotatorNotes T38	C0430888; Intraocular pressure test; Diagnostic Procedure
T39	DISO 1546 1554	catarata
#36	AnnotatorNotes T39	C0086543; Cataract; Anatomical Abnormality
T40	PROC 126 146	Comparar la eficacia
#37	AnnotatorNotes T40	C1707887; Efficacy Study; Research Activity
T41	Dose 14 21	al 0,1%
T42	Dose 40 45	al 1%
T43	Date 73 87	postoperatorio
#38	AnnotatorNotes T43	C0032790; Postoperative Period; Temporal Concept
T44	Date 237 251	postoperatorio
#39	AnnotatorNotes T44	C0032790; Postoperative Period; Temporal Concept
T45	LIVB 379 388	pacientes
#40	AnnotatorNotes T45	C0030705; Patients; Patient or Disabled Group
T46	Neg_cue 444 447	sin
T47	Time 463 479	intraoperatorias
#41	AnnotatorNotes T47	C0021891; Intraoperative Period; Temporal Concept | C0456904; Intraoperative; Temporal Concept
T48	LIVB 569 578	pacientes
#42	AnnotatorNotes T48	C0030705; Patients; Patient or Disabled Group
T49	Dose 605 612	al 0,1%
T50	Route 613 619	tópica
#43	AnnotatorNotes T50	C1522168; Topical Route of Drug Administration; Functional Concept
T51	LIVB 678 687	pacientes
#44	AnnotatorNotes T51	C0030705; Patients; Patient or Disabled Group
T52	Route 715 721	tópica
#45	AnnotatorNotes T52	C1522168; Topical Route of Drug Administration; Functional Concept
T53	LIVB 776 785	pacientes
#46	AnnotatorNotes T53	C0030705; Patients; Patient or Disabled Group
T56	Duration 966 978	las 24 horas
T57	Duration 984 987	mes
T58	Duration 1083 1095	las 24 horas
T59	Duration 1101 1104	mes
T61	Date 1514 1528	postoperatorio
#47	AnnotatorNotes T61	C0032790; Postoperative Period; Temporal Concept
T62	LIVB 311 319	cohortes
#48	AnnotatorNotes T62	C0599755; Cohort; Population Group
T63	Dose 190 192	1%
T64	Dose 214 218	0,1%
T65	Dose 712 714	1%
T54	ANAT 956 963	macular
#49	AnnotatorNotes T54	C0450295; Retinal macula; Body Part, Organ, or Organ Component | C1284755; Entire macula lutea; Body Part, Organ, or Organ Component
T55	PROC 917 931	grosor corneal
#50	AnnotatorNotes T55	C0412514; Corneal Pachymetry; Diagnostic Procedure
A1	Assertion T13 Negated
T60	Neg_cue 1314 1316	no
T66	CONC 1331 1338	cambios
A2	Assertion T66 Negated
#51	AnnotatorNotes T66	C0443172; Changed status; Quantitative Concept
R1	Negation Arg1:T60 Arg2:T66	
R2	Negation Arg1:T46 Arg2:T13	
R3	Has_Dose_or_Strength Arg1:T1 Arg2:T41	
R4	Has_Dose_or_Strength Arg1:T2 Arg2:T42	
R5	Before Arg1:T4 Arg2:T43	
R6	Overlap Arg1:T1 Arg2:T43	
R7	Overlap Arg1:T2 Arg2:T43	
R9	Causes Arg1:T6 Arg2:T5	
R10	Causes Arg1:T7 Arg2:T5	
R11	Has_Dose_or_Strength Arg1:T6 Arg2:T63	
R12	Has_Dose_or_Strength Arg1:T7 Arg2:T64	
R13	Used_for Arg1:T6 Arg2:T8	
R14	Used_for Arg1:T7 Arg2:T8	
R15	Overlap Arg1:T7 Arg2:T44	
R16	Overlap Arg1:T6 Arg2:T44	
R18	Before Arg1:T9 Arg2:T8	
R19	Before Arg1:T9 Arg2:T44	
R20	Experiences Arg1:T62 Arg2:T10	
R22	Experiences Arg1:T45 Arg2:T11	
R25	Experiences Arg1:T45 Arg2:T12	
R26	Experiences Arg1:T45 Arg2:T13	
R27	Overlap Arg1:T13 Arg2:T47	
R30	Experiences Arg1:T48 Arg2:T34	
R31	Experiences Arg1:T48 Arg2:T14	
R32	Has_Dose_or_Strength Arg1:T34 Arg2:T49	
R33	Has_Dose_or_Strength Arg1:T14 Arg2:T49	
R34	Has_Route_or_Mode Arg1:T14 Arg2:T50	
R35	Has_Route_or_Mode Arg1:T34 Arg2:T50	
R36	Used_for Arg1:T35 Arg2:T15	
R37	Used_for Arg1:T34 Arg2:T15	
R38	Used_for Arg1:T14 Arg2:T15	
R39	Experiences Arg1:T48 Arg2:T15	
#52	AnnotatorNotes T15	C1096024; Antiinflammatory therapy; Therapeutic or Preventive Procedure
R40	Experiences Arg1:T51 Arg2:T16	
R41	Has_Dose_or_Strength Arg1:T16 Arg2:T65	
R42	Has_Route_or_Mode Arg1:T16 Arg2:T52	
R43	Used_for Arg1:T16 Arg2:T17	
R44	Used_for Arg1:T14 Arg2:T17	
R45	Used_for Arg1:T34 Arg2:T17	
R46	Experiences Arg1:T53 Arg2:T36	
R47	Experiences Arg1:T53 Arg2:T18	
R48	Location_of Arg1:T37 Arg2:T18	
T67	Observation 883 888	flare
#53	AnnotatorNotes T67	C0423281; Anterior chamber flare; Finding
R49	Experiences Arg1:T53 Arg2:T67	
R50	Experiences Arg1:T53 Arg2:T38	
R51	Experiences Arg1:T53 Arg2:T55	
R52	Location_of Arg1:T20 Arg2:T55	
R53	Experiences Arg1:T53 Arg2:T21	
R54	Location_of Arg1:T54 Arg2:T21	
R55	Experiences Arg1:T53 Arg2:T22	
R56	Before Arg1:T22 Arg2:T21	
R57	Before Arg1:T22 Arg2:T55	
R58	Before Arg1:T22 Arg2:T38	
R59	Before Arg1:T22 Arg2:T67	
R60	Before Arg1:T22 Arg2:T18	
R61	Before Arg1:T22 Arg2:T36	
R62	Overlap Arg1:T36 Arg2:T56	
R63	Overlap Arg1:T36 Arg2:T57	
R64	Overlap Arg1:T18 Arg2:T56	
R65	Overlap Arg1:T18 Arg2:T57	
R66	Overlap Arg1:T67 Arg2:T56	
R67	Overlap Arg1:T67 Arg2:T57	
R68	Overlap Arg1:T38 Arg2:T56	
R69	Overlap Arg1:T38 Arg2:T57	
R70	Overlap Arg1:T55 Arg2:T56	
R71	Overlap Arg1:T55 Arg2:T57	
R72	Overlap Arg1:T21 Arg2:T56	
R73	Overlap Arg1:T21 Arg2:T57	
T68	PROC 1055 1080	test de medidas repetidas
#54	AnnotatorNotes T68	C0871881; repeated measures; Research Activity
R74	Overlap Arg1:T68 Arg2:T58	
R75	Overlap Arg1:T68 Arg2:T59	
T70	Observation 1211 1216	flare
#56	AnnotatorNotes T70	C0423281; Anterior chamber flare; Finding
T71	Observation 1183 1190	tyndall
#57	AnnotatorNotes T71	C4285973; Tyndall flare; Finding
R77	Overlap Arg1:T68 Arg2:T71	
R78	Overlap Arg1:T68 Arg2:T70	
R79	Before Arg1:T23 Arg2:T68	
R80	Before Arg1:T25 Arg2:T68	
T72	Quantifier_or_Qualifier 1339 1353	significativos
A3	Assertion T72 Negated
#58	AnnotatorNotes T72	C0750502; Significant; Idea or Concept
R83	Has_Quantifier_or_Qualifier Arg1:T66 Arg2:T72	
R84	Used_for Arg1:T26 Arg2:T29	
R85	Overlap Arg1:T26 Arg2:T61	
R86	Used_for Arg1:T27 Arg2:T29	
R87	Overlap Arg1:T27 Arg2:T61	
R88	Used_for Arg1:T28 Arg2:T29	
R89	Overlap Arg1:T28 Arg2:T61	
R90	Before Arg1:T30 Arg2:T29	
R92	Negation Arg1:T60 Arg2:T72	
R93	Experiences Arg1:T62 Arg2:T12	
R94	Experiences Arg1:T62 Arg2:T11	
R95	Experiences Arg1:T62 Arg2:T13	
R76	Overlap Arg1:T68 Arg2:T24	
A4	Experiencer T62 Patient
A5	Experiencer T45 Patient
A6	Experiencer T48 Patient
A7	Experiencer T51 Patient
A8	Experiencer T53 Patient
